These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25245932)

  • 21. [Systemic sclerosis].
    Peltomaa R; Pettersson T; Tuompo R; Luosujärvi R
    Duodecim; 2013; 129(19):1981-91. PubMed ID: 24218729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease.
    Silver RM; Warrick JH; Kinsella MB; Staudt LS; Baumann MH; Strange C
    J Rheumatol; 1993 May; 20(5):838-44. PubMed ID: 8336309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.
    Mangat P; Conron M; Gabbay E; Proudman SM;
    Intern Med J; 2010 Jul; 40(7):494-502. PubMed ID: 19460060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of cyclophospamide in the treatment of interstitial lung disease associated with systemic sclerosis.
    Espinosa G; Simeón CP; Plasín MÁ; Xaubet A; Muñoz X; Fonollosa V; Cervera R; Vilardell M
    Arch Bronconeumol; 2011 May; 47(5):239-45. PubMed ID: 21458128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-Associated Systemic Sclerosis: Literature Review and a Rare Case Report.
    Hasan S; Aqil M; Panigrahi R
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant systemic lupus erythematosus and HIV: case series and literature review.
    Mody GM; Patel N; Budhoo A; Dubula T
    Semin Arthritis Rheum; 2014 Oct; 44(2):186-94. PubMed ID: 24913962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful use of intravenous cyclophosphamide pulse therapy for interstitial lung disease in a patient with systemic sclerosis on hemodialysis.
    Takahashi T; Asano Y; Sunaga R; Ichimura Y; Taniguchi T; Yamamoto M; Tamaki Z; Takekoshi T; Mitsui H; Sugaya M; Ohse T; Sato S
    J Dermatol; 2014 Jun; 41(6):533-5. PubMed ID: 24814462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group.
    Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O;
    Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis.
    Broad K; Pope JE
    Med Sci Monit; 2010 Sep; 16(9):RA187-90. PubMed ID: 20802426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
    Furuya Y; Kuwana M
    J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?
    Burt RK; Oyama Y; Traynor A; Quigley K; Brush M; Rodriguez J; Barr WG
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S65-7. PubMed ID: 12931246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy.
    Hulgan T; Shepherd BE; Raffanti SP; Fusco JS; Beckerman R; Barkanic G; Sterling TR
    J Infect Dis; 2007 Feb; 195(3):425-31. PubMed ID: 17205482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic sclerosis.
    Ng SC
    Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexistence of systemic sclerosis and ankylosing spondylitis: A case report and literature review.
    Hu S; Zuo X; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1263-1265. PubMed ID: 30643074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reticulate hyperpigmentation in systemic sclerosis: a case report and review of the literature.
    Chuamanochan M; Haws AL; Pattanaprichakul P
    J Med Case Rep; 2015 Sep; 9():219. PubMed ID: 26412076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?].
    Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D
    Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current management strategies for systemic sclerosis.
    Nihtyanova SI; Ong VH; Denton CP
    Clin Exp Rheumatol; 2014; 32(2 Suppl 81):156-64. PubMed ID: 24742450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical characteristics of juvenile-onset systemic sclerosis in Japanese patients.
    Hatta Y; Hasegawa M; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
    Mod Rheumatol; 2014 Mar; 24(2):377-9. PubMed ID: 24593219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.